Efficacy News and Research

RSS
High-density genotyping array launched to study complexity of mouse genetics

High-density genotyping array launched to study complexity of mouse genetics

Single dose of Pain Therapeutics' PTI-188 decreased  melanoma tumors: Study

Single dose of Pain Therapeutics' PTI-188 decreased melanoma tumors: Study

Virginia-based medical practice implements CTT's pain therapy medical device

Virginia-based medical practice implements CTT's pain therapy medical device

Garnet BioTherapeutics commences treatment in GBT009 trial for incisional wounds following breast reconstruction surgery

Garnet BioTherapeutics commences treatment in GBT009 trial for incisional wounds following breast reconstruction surgery

BioSante Pharmaceuticals receives FDA Orphan Drug designation for GVAX AML Vaccine

BioSante Pharmaceuticals receives FDA Orphan Drug designation for GVAX AML Vaccine

Aradigm reports net loss of $3.4M for fourth-quarter 2009

Aradigm reports net loss of $3.4M for fourth-quarter 2009

Providence Service Corporation remarks on passage of health care reform bill

Providence Service Corporation remarks on passage of health care reform bill

Clinical Data completes NDA submission for vilazodone

Clinical Data completes NDA submission for vilazodone

Pfizer's Neurontin to earn 50% patient share in treatment of postherpetic neuralgia: Survey

Pfizer's Neurontin to earn 50% patient share in treatment of postherpetic neuralgia: Survey

Combining cognitive behavioral therapy with medication bupropion helps women quit smoking

Combining cognitive behavioral therapy with medication bupropion helps women quit smoking

FDA's ODAC voted to review T315I mutation prior to approval of OMAPRO

FDA's ODAC voted to review T315I mutation prior to approval of OMAPRO

Can-Fite BioPharma files patent application for treatment of Uveitis with A3 adenosine receptor ligands

Can-Fite BioPharma files patent application for treatment of Uveitis with A3 adenosine receptor ligands

Galderma Laboratories' Differin Lotion receives FDA approval

Galderma Laboratories' Differin Lotion receives FDA approval

Decision Resources forecasts multiple myeloma drug market to more than double from $2.1B in 2008 to $5.3B in 2018

Decision Resources forecasts multiple myeloma drug market to more than double from $2.1B in 2008 to $5.3B in 2018

Pevion Biotech commences Phase 1 clinical trial of PEV7 vaccine

Pevion Biotech commences Phase 1 clinical trial of PEV7 vaccine

BEMA Granisetron development program: BDSI announces positive meeting with FDA

BEMA Granisetron development program: BDSI announces positive meeting with FDA

ChemoCentryx undertakes Phase II clinical trial of CCX140

ChemoCentryx undertakes Phase II clinical trial of CCX140

Calando Pharmaceuticals demonstrates first targeted siRNA-containing nanoparticle delivery to tumors

Calando Pharmaceuticals demonstrates first targeted siRNA-containing nanoparticle delivery to tumors

Simcere Pharmaceutical completes Phase IV clinical study of Endostar

Simcere Pharmaceutical completes Phase IV clinical study of Endostar

Researchers develop new compound to inhibit HIV transmission

Researchers develop new compound to inhibit HIV transmission

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.